메뉴 건너뛰기




Volumn 153, Issue 4, 2007, Pages 559-565

Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FATALITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SUDDEN DEATH;

EID: 33947416635     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.008     Document Type: Article
Times cited : (70)

References (42)
  • 1
    • 0000454838 scopus 로고    scopus 로고
    • Insulin resistance: the fundamental trigger of type 2 diabetes
    • Groop L.C. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab 1 Suppl 1 (1999) S1-S7
    • (1999) Diabetes Obes Metab , vol.1 , Issue.SUPPL. 1
    • Groop, L.C.1
  • 2
    • 0027762766 scopus 로고
    • Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
    • Lillioja S., Mott D.M., Spraul M., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329 (1993) 1988-1992
    • (1993) N Engl J Med , vol.329 , pp. 1988-1992
    • Lillioja, S.1    Mott, D.M.2    Spraul, M.3
  • 3
    • 0026793446 scopus 로고
    • Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study
    • Martin B.C., Warram J.H., Krolewski A.S., et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340 (1992) 925-929
    • (1992) Lancet , vol.340 , pp. 925-929
    • Martin, B.C.1    Warram, J.H.2    Krolewski, A.S.3
  • 4
    • 14644390267 scopus 로고    scopus 로고
    • Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)
    • Adler A.I., Levy J.C., Matthews D.R., et al. Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67). Diabet Med 22 (2005) 306-311
    • (2005) Diabet Med , vol.22 , pp. 306-311
    • Adler, A.I.1    Levy, J.C.2    Matthews, D.R.3
  • 5
    • 0037882913 scopus 로고    scopus 로고
    • Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study
    • Resnick H.E., Jones K., Ruotolo G., et al. Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26 (2003) 861-867
    • (2003) Diabetes Care , vol.26 , pp. 861-867
    • Resnick, H.E.1    Jones, K.2    Ruotolo, G.3
  • 6
    • 0028139059 scopus 로고
    • Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991
    • Ferrara A., Barrett-Connor E.L., and Edelstein S.L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 140 (1994) 857-869
    • (1994) Am J Epidemiol , vol.140 , pp. 857-869
    • Ferrara, A.1    Barrett-Connor, E.L.2    Edelstein, S.L.3
  • 7
    • 0026728956 scopus 로고
    • Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913
    • Welin L., Eriksson H., Larsson B., et al. Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 35 (1992) 766-770
    • (1992) Diabetologia , vol.35 , pp. 766-770
    • Welin, L.1    Eriksson, H.2    Larsson, B.3
  • 8
    • 0035660210 scopus 로고    scopus 로고
    • Lack of association of insulin resistance and carotid intimal medial thickness in nondiabetic Asian Indian subjects
    • Snehalatha C., Vijay V., Suresh Mohan R., et al. Lack of association of insulin resistance and carotid intimal medial thickness in nondiabetic Asian Indian subjects. Diabetes Metab Res Rev 17 (2001) 444-447
    • (2001) Diabetes Metab Res Rev , vol.17 , pp. 444-447
    • Snehalatha, C.1    Vijay, V.2    Suresh Mohan, R.3
  • 9
    • 20044368678 scopus 로고    scopus 로고
    • Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp
    • Zethelius B., Lithell H., Hales C.N., et al. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 48 (2005) 862-867
    • (2005) Diabetologia , vol.48 , pp. 862-867
    • Zethelius, B.1    Lithell, H.2    Hales, C.N.3
  • 10
    • 0345698971 scopus 로고    scopus 로고
    • Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study
    • Pyorala M., Miettinen H., Laakso M., et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 98 (1998) 398-404
    • (1998) Circulation , vol.98 , pp. 398-404
    • Pyorala, M.1    Miettinen, H.2    Laakso, M.3
  • 11
    • 2542507751 scopus 로고    scopus 로고
    • Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men
    • Lempiainen P., Mykkanen L., Pyorala K., et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100 (1999) 123-128
    • (1999) Circulation , vol.100 , pp. 123-128
    • Lempiainen, P.1    Mykkanen, L.2    Pyorala, K.3
  • 12
    • 0029862973 scopus 로고    scopus 로고
    • Hyperinsulinemia as an independent risk factor for ischemic heart disease
    • Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
    • (1996) N Engl J Med , vol.334 , pp. 952-957
    • Despres, J.P.1    Lamarche, B.2    Mauriege, P.3
  • 13
    • 0037322198 scopus 로고    scopus 로고
    • Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: the Malmo Preventive Project
    • Nilsson P., Nilsson J.A., Hedblad B., et al. Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: the Malmo Preventive Project. J Intern Med 253 (2003) 136-145
    • (2003) J Intern Med , vol.253 , pp. 136-145
    • Nilsson, P.1    Nilsson, J.A.2    Hedblad, B.3
  • 14
    • 30744460648 scopus 로고    scopus 로고
    • Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study
    • Rutter M.K., Meigs J.B., Sullivan L.M., et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54 (2005) 3252-3257
    • (2005) Diabetes , vol.54 , pp. 3252-3257
    • Rutter, M.K.1    Meigs, J.B.2    Sullivan, L.M.3
  • 15
    • 20244370323 scopus 로고
    • Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)
    • Goldbourt U., Behar S., Reicher-Reiss H., et al. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol 71 (1993) 909-915
    • (1993) Am J Cardiol , vol.71 , pp. 909-915
    • Goldbourt, U.1    Behar, S.2    Reicher-Reiss, H.3
  • 16
    • 0034604225 scopus 로고    scopus 로고
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 102 (2000) 21-27
    • (2000) Circulation , vol.102 , pp. 21-27
  • 17
    • 26444604923 scopus 로고    scopus 로고
    • Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
    • Tenenbaum A., Motro M., Fisman E.Z., et al. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J 26 (2005) 2032-2038
    • (2005) Eur Heart J , vol.26 , pp. 2032-2038
    • Tenenbaum, A.1    Motro, M.2    Fisman, E.Z.3
  • 18
    • 1842334456 scopus 로고    scopus 로고
    • Report of the expert committees on the diagnosis and classification of diabetes mellitus
    • American Diabetes Association. Report of the expert committees on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
    • (1997) Diabetes Care , vol.20 , pp. 1183-1197
    • American Diabetes Association1
  • 19
    • 2442660528 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
    • Tenenbaum A., Motro M., Fisman E.Z., et al. Peroxisome proliferator-activated receptors ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 109 (2004) 2197-2202
    • (2004) Circulation , vol.109 , pp. 2197-2202
    • Tenenbaum, A.1    Motro, M.2    Fisman, E.Z.3
  • 21
    • 0942298680 scopus 로고    scopus 로고
    • Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance
    • Yanase M., Takatsu F., Tagawa T., et al. Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance. Circ J 68 (2004) 47-52
    • (2004) Circ J , vol.68 , pp. 47-52
    • Yanase, M.1    Takatsu, F.2    Tagawa, T.3
  • 22
    • 2542475544 scopus 로고    scopus 로고
    • Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men
    • Zethelius B., Hales C.N., Lithell H.O., et al. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27 (2004) 1433-1438
    • (2004) Diabetes Care , vol.27 , pp. 1433-1438
    • Zethelius, B.1    Hales, C.N.2    Lithell, H.O.3
  • 23
    • 0033533596 scopus 로고    scopus 로고
    • Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association
    • Grundy S.M., Benjamin I.J., Burke G.L., et al. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
    • (1999) Circulation , vol.100 , pp. 1134-1146
    • Grundy, S.M.1    Benjamin, I.J.2    Burke, G.L.3
  • 24
    • 0036637538 scopus 로고    scopus 로고
    • Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart study
    • Hanley A.J., Williams K., Stern M.P., et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart study. Diabetes Care 25 (2002) 1177-1184
    • (2002) Diabetes Care , vol.25 , pp. 1177-1184
    • Hanley, A.J.1    Williams, K.2    Stern, M.P.3
  • 25
    • 1542513468 scopus 로고    scopus 로고
    • Correlation between cardiovascular disease and diabetes mellitus: current concepts
    • Nesto R.W. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med 116 Suppl 5A (2004) 11S-22S
    • (2004) Am J Med , vol.116 , Issue.SUPPL. 5A
    • Nesto, R.W.1
  • 26
    • 0027512732 scopus 로고
    • Role of insulin resistance in human disease (syndrome X): an expanded definition
    • Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44 (1993) 121-131
    • (1993) Annu Rev Med , vol.44 , pp. 121-131
    • Reaven, G.M.1
  • 27
    • 10344259100 scopus 로고    scopus 로고
    • Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?
    • Jadhav S., Petrie J., Ferrell W., et al. Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?. Heart 90 (2004) 1379-1383
    • (2004) Heart , vol.90 , pp. 1379-1383
    • Jadhav, S.1    Petrie, J.2    Ferrell, W.3
  • 28
    • 0033983242 scopus 로고    scopus 로고
    • Insulin action is associated with endothelial function in hypertension and type 2 diabetes
    • Cleland S.J., Petrie J.R., Small M., et al. Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 35 (2000) 507-511
    • (2000) Hypertension , vol.35 , pp. 507-511
    • Cleland, S.J.1    Petrie, J.R.2    Small, M.3
  • 29
    • 4644318535 scopus 로고    scopus 로고
    • Macrovascular complications of metabolic syndrome: an early intervention is imperative
    • Tenenbaum A., Motro M., Schwammenthal E., et al. Macrovascular complications of metabolic syndrome: an early intervention is imperative. Int J Cardiol 97 (2004) 167-172
    • (2004) Int J Cardiol , vol.97 , pp. 167-172
    • Tenenbaum, A.1    Motro, M.2    Schwammenthal, E.3
  • 30
    • 0023232216 scopus 로고
    • Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • Frick M.H., Elo O., Haapa K., et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317 (1987) 1237-1245
    • (1987) N Engl J Med , vol.317 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 31
    • 0033527030 scopus 로고    scopus 로고
    • Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
    • Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341 (1999) 410-418
    • (1999) N Engl J Med , vol.341 , pp. 410-418
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3
  • 32
    • 19344375593 scopus 로고    scopus 로고
    • Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome
    • Tenenbaum A., Motro M., Fisman E.Z., et al. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med 165 (2005) 1154-1160
    • (2005) Arch Intern Med , vol.165 , pp. 1154-1160
    • Tenenbaum, A.1    Motro, M.2    Fisman, E.Z.3
  • 33
    • 26244453309 scopus 로고    scopus 로고
    • PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
    • Dormandy J.A., Charbonnel B., Eckland D.J., et al. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.3
  • 34
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
    • Keech A., Simes R.J., Barter P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3
  • 35
    • 0018520840 scopus 로고
    • Glucose clamp technique: a method for quantifying insulin secretion and resistance
    • DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
    • (1979) Am J Physiol , vol.237
    • DeFronzo, R.A.1    Tobin, J.D.2    Andres, R.3
  • 36
    • 0030994947 scopus 로고    scopus 로고
    • The homeostasis model in the San Antonio Heart Study
    • Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 (1997) 1087-1092
    • (1997) Diabetes Care , vol.20 , pp. 1087-1092
    • Haffner, S.M.1    Miettinen, H.2    Stern, M.P.3
  • 37
    • 0035095052 scopus 로고    scopus 로고
    • Diagnosing insulin resistance in the general population
    • McAuley K.A., Williams S.M., Mann J.I., et al. Diagnosing insulin resistance in the general population. Diabetes Care 24 (2001) 460-464
    • (2001) Diabetes Care , vol.24 , pp. 460-464
    • McAuley, K.A.1    Williams, S.M.2    Mann, J.I.3
  • 38
    • 0035081231 scopus 로고    scopus 로고
    • Clinical significance of the insulin resistance index as assessed by homeostasis model assessment
    • Ikeda Y., Suehiro T., Nakamura T., et al. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 48 (2001) 81-86
    • (2001) Endocr J , vol.48 , pp. 81-86
    • Ikeda, Y.1    Suehiro, T.2    Nakamura, T.3
  • 39
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 40
    • 33645738300 scopus 로고    scopus 로고
    • Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate
    • Tenenbaum A., Fisman E.Z., Boyko V., et al. Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med 166 (2006) 737-741
    • (2006) Arch Intern Med , vol.166 , pp. 737-741
    • Tenenbaum, A.1    Fisman, E.Z.2    Boyko, V.3
  • 41
    • 19944433634 scopus 로고    scopus 로고
    • Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance
    • Hung Y.J., Hsieh C.H., Pei D., et al. Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. Clin Endocrinol (Oxf) 62 (2005) 85-91
    • (2005) Clin Endocrinol (Oxf) , vol.62 , pp. 85-91
    • Hung, Y.J.1    Hsieh, C.H.2    Pei, D.3
  • 42
    • 17444420663 scopus 로고    scopus 로고
    • Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue
    • Rasouli N., Raue U., Miles L.M., et al. Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue. Am J Physiol Endocrinol Metab 288 (2005) E930-E934
    • (2005) Am J Physiol Endocrinol Metab , vol.288
    • Rasouli, N.1    Raue, U.2    Miles, L.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.